Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
Ključne riječi
Sažetak
Opis
Several studies have shown an association between hypertriacylglycerolaemia and coronary artery disease. Additionally, ectopic fat distribution, in particular, deposition of excess lipid within the liver and skeletal muscle, has been shown to correlate negatively with insulin sensitivity, thus presenting a metabolic milieu in which risk of developing type 2 diabetes is elevated. Previous research from our group has shown that the triacylglycerol (TAG) concentration within the liver, and within skeletal muscle fibres IMCLs (intramyocellular lipids), is increased in elderly individuals compared with young people. The elevation of lipids in these particular tissues for the elderly group was observed despite no statistically significant difference in fasting plasma TAG concentration. As the plasma TAG concentration during the postabsorptive state is largely determined by the production and clearance rates of very low density lipoprotein triacylglycerol (VLDL-TAG), and increased liver fat content has been shown to drive production of large VLDL particles, it is important to gain an understanding of whether VLDL synthesis and breakdown differs between young and elderly individuals. Such new knowledge may offer an insight into why tissue lipids are elevated in the elderly. At present, no data exist in the literature describing VLDL turnover in elderly people. We hypothesise that very low density lipoprotein turnover will be reduced in elderly individuals compared with young people. The aims of this study are a) to determine whether fractional synthesis and breakdown rates of both the protein and lipid parts of the VLDL are different between young and elderly individuals, and b) to determine whether VLDL turnover values appear different when calculated using a constant infusion tracer method as compared with a bolus tracer method. Eight young men, eight young women, eight elderly men and eight elderly women will each participate in an 8-hour infusion study. Stable isotopes of glycerol, amino acids and fatty acids will be infused, and blood samples will be drawn in intervals during the study.
Datumi
| Posljednja provjera: | 04/30/2016 |
| Prvo podneseno: | 04/09/2014 |
| Predviđena prijava poslana: | 04/09/2014 |
| Prvo objavljeno: | 04/13/2014 |
| Posljednje ažuriranje poslano: | 05/09/2016 |
| Posljednje ažuriranje objavljeno: | 05/11/2016 |
| Stvarni datum početka studija: | 11/30/2011 |
| Procijenjeni datum primarnog završetka: | 06/30/2013 |
| Procijenjeni datum završetka studije: | 06/30/2013 |
Stanje ili bolest
Intervencija / liječenje
Procedure: Stable Isotope Infusion
Faza
Grupe ruku
| Ruka | Intervencija / liječenje |
|---|---|
| Young Males Males, age 18-35 years. 9-hour Stable isotope infusion | |
| Young Females Females, age 18-35 years. 9-hour Stable isotope infusion | |
| Older Males Males, age 60-75. 9-hour Stable isotope infusion | |
| Older Females Females, age 60-75. 9-hour Stable isotope infusion |
Kriterij prihvatljivosti
| Dobni uvjeti za studiranje | 60 Years Do 60 Years |
| Spolovi koji ispunjavaju uvjete za studij | All |
| Metoda uzorkovanja | Probability Sample |
| Prihvaća zdrave volontere | Da |
| Kriteriji | Inclusion Criteria: - Age 18 to 35 years, or 60 to 75 years. - Body mass index ≤ 27 kg•m2 - Ability to sign informed consent. - Score of ≥26 for Mini-Mental State Exam Exclusion Criteria: - Diabetics (plasma glucose concentration >200 mg/dl at 2 hr after oral intake of 75 g glucose). - Fasting plasma triacylglycerol concentration above 500 mg/dl - Kidney disease. - Liver disease. - Bleeding disorders. - Anaemia (Hb < 13 g/dl in males or < 12 g/dl in females). - Endocrine disease (with the exception of well-regulated hypothyroidism). - Positive hepatitis or HIV screens. - Alcohol (CAGE questionnaire; abnormal liver enzyme values) or drug abuse (amphetamines, cocaine, opioids, marijuana). - Lipid altering agents. - Score of <26 for Mini-Mental State Exam |
Ishod
Primarne mjere ishoda
1. Very Low Density Lipoprotein (VLDL) Turnover [9-hours]
